President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...
Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...
In today's Pharmalittle roundup, we're reading about Medicare negotiations, U.K. drug rebates rising, and more.
As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...
The Inflation Reduction Act was passed in 2021 to reduce the government deficit, incentivize domestic energy production, and ...
Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...
Just before the inauguration, the outgoing Biden administration announced 15 new medications that'll be subject to government ...
SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...
Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...
A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme, rejecting the ...